36C25726D0022
Indefinite Delivery Contract
Overview
Government Description
AMARILLO VA PHARMACY COMPOUNDING IDIQ FOR ONCOLOGY MEDICATIONS
Awardee
Awarding / Funding Agency
Pricing
Fixed Price
Set Aside
None
Extent Competed
Competed Under Simplified Acquisition Procedures
Multiple / Single Award
Single Award
Who Can Use
Single Agency
Individual Order Limit
$240,000
Vehicle Ceiling
$500,000 (0% Used)
Related Opportunity
Optum Infusion Services 308 was awarded
Indefinite Delivery Contract 36C25726D0022 (36C257-26-D-0022)
by
the VISN 17: Heart of Texas Health Care Network
for Amarillo Va Pharmacy Compounding Idiq For Oncology Medications
in October 2025.
The IDC
has a duration of 5 years and
was awarded
through solicitation Amarillo (AMA) Pharmacy Compounding Oncology
full & open
with
NAICS 325412 and
PSC 6505
via simplified acquisition acquisition procedures with 1 bid received.
The total ceiling is $500,000, of which 0% has been used.
Status
(Open)
Modified 10/14/25
Period of Performance
10/31/25
Start Date
10/31/30
Ordering Period End Date
Task Order Obligations
$0
Total Obligated
$0
Current Award
$0
Potential Award
Opportunity Lifecycle
Procurement history for 36C25726D0022
Transaction History
Modifications to 36C25726D0022
People
Suggested agency contacts for 36C25726D0022
Competition
Number of Bidders
1
Solicitation Procedures
Simplified Acquisition
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
RN5UVE9XMJN4
Awardee CAGE
9HGM2
Agency Detail
Awarding Office
36C257 257-NETWORK CONTRACT OFFICE 17 (36C257)
Funding Office
36C504 504-AMARILLO (00504)
Created By
jennifer.stringer@va.gov
Last Modified By
jennifer.stringer@va.gov
Approved By
jennifer.stringer@va.gov
Legislative
Legislative Mandates
None Applicable
Awardee District
AZ-04
Senators
Kyrsten Sinema
Mark Kelly
Mark Kelly
Representative
Greg Stanton
Last Modified: 10/14/25